13G Filing: James E. Flynn and Audentes Therapeutics Inc (BOLD)

Page 15 of 18

Page 15 of 18 – SEC Filing

CUSIP No. 05070R104 13G Page 15 of
15

JAMES E. FLYNN

/s/ Jonathan Isler

Jonathan Isler, Attorney-In-Fact

Date: April 25, 2017

Follow Audentes Therapeutics Inc. (NASDAQ:BOLD)

Page 15 of 18